DREAMM9

A Phase 1 Study of Belantamab Mafodotin Plus Standard of Care in Newly Diagnosed Multiple Myeloma

What's the purpose of the trial?

This goal of this Phase 1 clinical trial is to test how safe and effective belantamab mafodotin is when combined with bortezomib, lenalidomide, and dexamethasone. Researchers want to determine the safest and most effective dose of belantamab mafodotin, and study whether it can improve your myeloma when combined with the other study drugs.

Trial status

Accepting patients

Phase
Phase 1
Enrollment
144
Last Updated
2 weeks ago
Am I Eligible

Participating Centers

There are 6 centers participating in this trial. Enter a location below to find the closest center.

Experimental Treatments

Learn more about the experimental treatments being evaluated in this clinical trial.

  • Belantamab Mafodotin
  • Bortezomib
  • Dexamethasone
  • Lenalidomide

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.